Association of body mass index (BMI) with clinical efficacy of immune checkpoint inhibitors (ICI) in advanced cancer patients: A retrospective analysis.

Raphael Brandao Moreira,Maurício Fernandes,Mariana Ribeiro Monteiro,Francine Luiz,Erika Simplicio,Perla de Mello Andrade,Mayara Batista,Letycia Lima,Astrid Silva,Juliana Nuňez,Daniele Freitas,Luiz H. Araujo,Pedro Nazareth Aguiar

Association of body mass index (BMI) with clinical efficacy of immune checkpoint inhibitors (ICI) in advanced cancer patients: A retrospective analysis.

2020

Raphael Brandao Moreira
Maurício Fernandes
Mariana Ribeiro Monteiro
Francine Luiz
Erika Simplicio
Perla de Mello Andrade
Mayara Batista
Letycia Lima
Astrid Silva
Juliana Nuňez
Daniele Freitas
Luiz H. Araujo
Pedro Nazareth Aguiar

e15066Background: Obesity is linked to an increased risk of cancer development. The excess of body fatness seems to be associated with alterations in hormonal, metabolic and inflammatory pathways, ...

Keywords:

retrospective analysis
Internal medicine
Oncology
Medicine
clinical efficacy
Body mass index
advanced cancer
immune checkpoint inhibitors
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations